AUG 14, 2019 2:15 PM PDT

New drug to treat opioid use disorder during pregnancy is favorable for mom, and baby

On average, a baby is born in withdrawal from opioids every 15 minutes in the U.S., according to recent research.

Opioid use during pregnancy can result in a drug withdrawal syndrome in newborns called neonatal abstinence syndrome or neonatal opioid withdrawal syndrome (NAS/ NOWS). About 50 to 80 percent of opioid-exposed infants require medication to manage their withdrawal symptoms, which typically manifest a few days after birth. These include irritability, difficulty soothing, trouble eating and sleeping, and diarrhea.

Naltrexone, buprenorphine, and methadone are three FDA-approved drugs prescribed to treat opioid use disorder. However, there are very few studies on the use and safety of naltrexone during pregnancy because the drug is new on the market. In a study published in Clinical Therapeutics, researchers followed mothers and their infants during pregnancy and after delivery from 2017 to 2019. Six of the mothers took naltrexone to treat their opioid use disorder before and during pregnancy, and 12 took buprenorphine. Researchers carefully monitored patients' opioid use, gestational age, birth weight, NICU admission and importantly, NOWS outcomes (i.e., diagnosis, medical treatment, and length of hospital stay).

Astonishingly, the infants born to women taking naltrexone showed no withdrawal symptoms during their initial hospital stays, compared to 92 percent of infants born to women taking buprenorphine. Also, 83 percent of the women in the naltrexone group breastfed, without any immediate harm to their infants in the perinatal period.

Previous studies compared methadone and buprenorphine use during pregnancy and found that buprenorphine was associated with less severe NOWS in infants compared to infants born to mothers who took methadone. Based on the current study, however, it seems that naltrexone may now be preferred over buprenorphine due to positive outcomes for both mother and baby.

Additionally, naltrexone may be safer than buprenorphine because it is administered as an extended-release injection medication, and has a lower risk of overdose or misuse. Perhaps the most important aspect of treating opioid use disorder during pregnancy is keeping mothers stable on their medication to decrease the risk of drug relapse, noted authors.

Source: EurekAlert!, ScienceDaily

About the Author
You May Also Like
MAR 15, 2021
Cardiology
'Silent' Heart Attacks Linked to Significant Increase in Stroke Risk
MAR 15, 2021
'Silent' Heart Attacks Linked to Significant Increase in Stroke Risk
Silent heart attacks can happen, in which blood flow to the heart is blocked, and heart tissue may be damaged, but they ...
MAR 25, 2021
Genetics & Genomics
Sperm's Molecular 'Memory' Is Revealed
MAR 25, 2021
Sperm's Molecular 'Memory' Is Revealed
The human genome contains the genes that make us who we are, because of how and when those genes are expressed. Gene exp ...
APR 13, 2021
Clinical & Molecular DX
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
APR 13, 2021
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
German researchers have developed an innovative method for continuously tracking and monitoring biomarkers and drugs cir ...
APR 15, 2021
Clinical & Molecular DX
A Portable Ebola Detector, 1000x More Sensitive Than Lab-Based Tests
APR 15, 2021
A Portable Ebola Detector, 1000x More Sensitive Than Lab-Based Tests
Duke University scientists have created a highly sensitive Ebola virus portable diagnostic device, 1000 times more sensi ...
APR 12, 2021
Health & Medicine
Chronic Pain Patients Can Find Long-Term Success Using Cannabis
APR 12, 2021
Chronic Pain Patients Can Find Long-Term Success Using Cannabis
Many users report immediate pain relief from using medical cannabis, but now a recently published study suggests chronic ...
APR 15, 2021
Cell & Molecular Biology
In a Twist, Researchers Suggest Some Alzheimer Plaques are Protective
APR 15, 2021
In a Twist, Researchers Suggest Some Alzheimer Plaques are Protective
Scientists have long known that in Alzheimer's disease, plaques form in the brain. But new research suggests that not al ...
Loading Comments...